137 related articles for article (PubMed ID: 1378038)
1. Transplantation of organs between species.
White DJ
Int Arch Allergy Immunol; 1992; 98(1):1-5. PubMed ID: 1378038
[TBL] [Abstract][Full Text] [Related]
2. Membrane-associated proteins regulating the complement system: functions and deficiencies.
Schieren G; Hänsch GM
Int Rev Immunol; 1993; 10(1):87-101. PubMed ID: 7688019
[No Abstract] [Full Text] [Related]
3. Decay-accelerating factor and membrane cofactor protein.
Lublin DM; Atkinson JP
Curr Top Microbiol Immunol; 1990; 153():123-45. PubMed ID: 1688754
[No Abstract] [Full Text] [Related]
4. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
Gorter A; Meri S
Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
[TBL] [Abstract][Full Text] [Related]
5. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
[TBL] [Abstract][Full Text] [Related]
6. Ethical considerations in clinical cardiac xenografting.
Pierson RN; White DJ; Wallwork J
J Heart Lung Transplant; 1993; 12(5):876-8. PubMed ID: 7694655
[No Abstract] [Full Text] [Related]
7. The regulation of the complement system: insights from genetically-engineered mice.
Turnberg D; Botto M
Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
[TBL] [Abstract][Full Text] [Related]
8. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
Transpl Int; 1992; 5 Suppl 1():S648-50. PubMed ID: 14621899
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of human membrane cofactor protein in transgenic mice.
IJzermans JN; Schraa EO; Bonthuis F; Yannnoutsos N; Marquet RL
Transplant Proc; 1996 Apr; 28(2):671-2. PubMed ID: 8623336
[No Abstract] [Full Text] [Related]
10. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.
Atkinson JP; Oglesby TJ; White D; Adams EA; Liszewski MK
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):27-30. PubMed ID: 1718640
[No Abstract] [Full Text] [Related]
11. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
12. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
13. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
[No Abstract] [Full Text] [Related]
14. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
[No Abstract] [Full Text] [Related]
15. Prolonged survival of discordant xenografts in a subset of complement-depleted nude rats.
Fryer JP; Chen S; Johnson EM; Simone P; Sun LH; Goswitz JJ; Matas AJ
Transplant Proc; 1996 Apr; 28(2):700. PubMed ID: 8623353
[No Abstract] [Full Text] [Related]
16. A study of human DAF, CD59, MCP transgene in xenotransplantation.
Chen S; Chen G; Cai CC; Wang XM; Guo H; Shen SQ; Wang H; Wu Y; Li GX; Huang J; Li WX; Wei QX; Sun FZ
Transplant Proc; 2001; 33(7-8):3851-2. PubMed ID: 11750639
[No Abstract] [Full Text] [Related]
17. Transgenic expression of a CD46 (membrane cofactor protein) minigene: studies of xenotransplantation and measles virus infection.
Thorley BR; Milland J; Christiansen D; Lanteri MB; McInnes B; Moeller I; Rivailler P; Horvat B; Rabourdin-Combe C; Gerlier D; McKenzie IF; Loveland BE
Eur J Immunol; 1997 Mar; 27(3):726-34. PubMed ID: 9079815
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation].
Heckl-Ostreicher B; Kirschfink M
Immun Infekt; 1995 Apr; 23(2):53-4. PubMed ID: 7538095
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease.
Davies ME; Horner A; Loveland BE; McKenzie IF
Scand J Rheumatol; 1994; 23(6):316-21. PubMed ID: 7528443
[TBL] [Abstract][Full Text] [Related]
20. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats.
Lin Y; Vandeputte M; Waer M
Transplantation; 1998 Feb; 65(3):332-9. PubMed ID: 9484748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
